Fig. 1 · Structure
Documents & Downloads
Dihydro-β-erythroidine
Nicotinic Receptor Antagonist
Dihydro-β-erythroidine is a competitive antagonist of nicotinic receptors, specifically targeting α4β2 subtypes. It effectively inhibits the discriminative stimulus properties associated with nicotine, as well as the anxiolytic effects induced by nicotine. This compound is widely utilized in neuropharmacological research to explore the role of nicotinic receptors in addiction, anxiety, and related behaviors.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 23255-54-1 |
| Applications | Nicotinic Receptor Antagonist |
| Formula | C16H21NO3 |
| Molecular Weight | 275.34 |
| SMILES | CO[C@H]1CC=C2CCN3CCC4=C([C@@]32C1)CC(OC4)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.